Azzad Asset Management’s Strata Skin Sciences SSKN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-21,800
| Closed | -$44.9K | – | 353 |
|
|
2025
Q3 | $44.9K | Buy |
21,800
+9,800
| +82% | +$19.4K | ﹤0.01% | 324 |
|
|
2025
Q2 | $27.5K | Buy |
12,000
+1,000
| +9% | +$2.5K | ﹤0.01% | 311 |
|
|
2025
Q1 | $29K | Buy |
+11,000
| New | +$30.6K | ﹤0.01% | 299 |
|
|
2024
Q4 | – | Sell |
-12,000
| Closed | -$33K | – | 292 |
|
|
2024
Q3 | $33K | Buy |
+12,000
| New | +$37.5K | ﹤0.01% | 305 |
|
|
2024
Q2 | – | Sell |
-6,700
| Closed | -$25.3K | – | 315 |
|
|
2024
Q1 | $25.3K | Buy |
6,700
+4,980
| +290% | +$26K | ﹤0.01% | 301 |
|
|
2023
Q4 | $9.46K | Sell |
1,720
-3,730
| -68% | -$19.4K | ﹤0.01% | 304 |
|
|
2023
Q3 | $32.4K | Buy |
5,450
+1,770
| +48% | +$13.6K | ﹤0.01% | 302 |
|
|
2023
Q2 | $35K | Buy |
3,680
+130
| +4% | +$1.28K | ﹤0.01% | 319 |
|
|
2023
Q1 | $37.6K | Sell |
3,550
-780
| -18% | -$7.84K | 0.01% | 314 |
|
|
2022
Q4 | $34.2K | Sell |
4,330
-320
| -7% | -$2.75K | 0.01% | 310 |
|
|
2022
Q3 | $41.5K | Buy |
4,650
+970
| +26% | +$9.85K | ﹤0.01% | 398 |
|
|
2022
Q2 | $36K | Buy |
3,680
+1,480
| +67% | +$17.6K | ﹤0.01% | 392 |
|
|
2022
Q1 | $32.3K | Sell |
2,200
-100
| -4% | -$1.49K | ﹤0.01% | 321 |
|
|
2021
Q4 | $33.7K | Buy |
2,300
+570
| +33% | +$9.46K | ﹤0.01% | 327 |
|
|
2021
Q3 | $31.8K | Sell |
1,730
-250
| -13% | -$3.81K | ﹤0.01% | 324 |
|
|
2021
Q2 | $30.9K | Buy |
+1,980
| New | +$30.8K | ﹤0.01% | 323 |
|
|
2018
Q2 | – | Sell |
-1,120
| Closed | -$13.1K | – | 314 |
|
|
2018
Q1 | $13.1K | Buy |
+1,120
| New | +$14.9K | ﹤0.01% | 297 |
|
|
2017
Q4 | – | Sell |
-2,680
| Closed | -$47.4K | – | 294 |
|
|
2017
Q3 | $47.4K | Buy |
2,680
+1,120
| +72% | +$20.6K | 0.02% | 284 |
|
|
2017
Q2 | $37.9K | Buy |
1,560
+660
| +73% | +$18.4K | 0.01% | 288 |
|
|
2017
Q1 | $27.2K | Sell |
900
-14
| -2% | -$398 | 0.01% | 251 |
|
|
2016
Q4 | $20.1K | Buy |
914
+90
| +11% | +$2.3K | 0.01% | 231 |
|
|
2016
Q3 | $21.8K | Buy |
824
+124
| +18% | +$3.95K | 0.01% | 236 |
|
|
2016
Q2 | $21.4K | Buy |
700
+192
| +38% | +$7.73K | 0.01% | 236 |
|
|
2016
Q1 | $24K | Buy |
508
+34
| +7% | +$1.76K | 0.01% | 232 |
|
|
2015
Q4 | $26.3K | Buy |
474
+90
| +23% | +$5.14K | 0.01% | 234 |
|
|
2015
Q3 | $21.9K | Buy |
384
+48
| +14% | +$2.78K | 0.01% | 244 |
|
|
2015
Q2 | $19.3K | Buy |
+336
| New | +$27.4K | 0.01% | 252 |
|
|
2015
Q1 | – | Sell |
-257
| Closed | -$15.4K | – | 272 |
|
|
2014
Q4 | $15.4K | Buy |
+257
| New | +$21.1K | 0.01% | 273 |
|
|
2014
Q3 | – | Sell |
-114
| Closed | -$18.3K | – | 293 |
|
|
2014
Q2 | $18.3K | Buy |
114
+75
| +192% | +$17K | 0.01% | 269 |
|
|
2014
Q1 | $12.2K | Buy |
39
+7
| +22% | +$2.46K | 0.01% | 258 |
|
|
2013
Q4 | $10.2K | Buy |
32
+9
| +39% | +$3.22K | 0.01% | 250 |
|
|
2013
Q3 | $8.25K | Hold |
23
| – | – | 0.01% | 234 |
|
|
2013
Q2 | $8.25K | Buy |
+23
| New | +$12.3K | 0.01% | 231 |
|
Other funds holding SSKN
2L
NCM
AWM
TSS
TRCT
Azzad Asset Management's SSKN Position: Q4 2025 in Review
Azzad Asset Management sold out of Strata Skin Sciences (SSKN) in Q4 2025, closing a stake of 21,800 shares — an estimated $44.9K sold.
Azzad Asset Management first reported a position in SSKN in Q2 2013 and held it in 33 quarters. The position peaked at $47.4K in Q3 2017. 14 funds tracked by Wall St. Rank hold SSKN as of Q4 2025.
- Azzad Asset Management reported no remaining Strata Skin Sciences position as of Q4 2025 after selling out during the quarter.
- Azzad Asset Management sold 21,800 Strata Skin Sciences shares in Q4 2025, an estimated $44.9K.
- Azzad Asset Management first reported a position in Strata Skin Sciences in Q2 2013 and held it in 33 quarters.
- Azzad Asset Management's Strata Skin Sciences position peaked at $47.4K in Q3 2017.
- 14 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q4 2025.
Based on Azzad Asset Management's 13F filing for Q4 2025, filed 21 Jan 2026.